Current position:Home >Product >
(AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID
(AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID(569371-10-4)
- Name: (AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID
- Synonyms:(AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID;UBP 301;(aS)-a-Amino-3-((4-carboxyphenyl)methyl)-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoicacid
- Molecular Formula:C15H14IN3O6
- Molecular Weight:459.19
- CAS Registry Number:569371-10-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.569371-10-4 UBP 301
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.569371-10-4 UBP 301
Assay:鈮?8% by HPLC Package:inquiry Transportation:inquiry Application:UBP 301 is a potent kainate receptor antagonist (apparent Kd = 5.94 渭M), displaying ~ 30-fold selectivity over AMPA receptors.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 568598-07-2/1H-Pyrazole-3-ethanamine,N,N,5-trimethyl-(9CI)
- 569315-05-5/Oxazole, 4,5-dihydro-4-methoxy-2-phenyl- (9CI)
- 569322-21-0/Pyridine,2-[(methylseleno)bis(trimethylsilyl)methyl]-(9CI)
- 569328-44-5/4,5-Pyridazinediol, hexahydro-3-(hydroxymethyl)-, conjugate monoacid, (3R,4S,5R)- (9CI)
- 569328-59-2/4,5-Pyridazinediol, hexahydro-3-(hydroxymethyl)-, conjugate monoacid, (3R,4R,5R)- (9CI)
- 569329-55-1/(6-METHOXY-4-QUINOLYL)(5-VINYL-1-AZABICYCLO[2.2.2]OCT-2-YL)METHANONE
- 569336-08-9/1H-Pyrimido[1,2-a]quinoline-8,9-diol, 2,3,5,6-tetrahydro- (9CI)
- 569336-79-4/2,4,6(1H,3H,5H)-Pyrimidinetrione,1-ethyl-5-methyl-5-(propylamino)-(9CI)
- 569336-80-7/2,4,6(1H,3H,5H)-Pyrimidinetrione,1-ethyl-5-methyl-5-[(1-methylethyl)amino]-(9CI)
- 569339-15-7/Benzamide, 3-mercapto- (9CI)
- 569341-41-9/Thieno[2,3-c]furan-4(2H)-one, 3,6-dihydro-3-hydroxy- (9CI)
- 569343-09-5/1,3,2-DIOXABOROLANE, 2-(9,9-DIMETHYL-9H-FLUOREN-2-YL)-4,4,5,5-TETRAMETHYL
- 569344-34-9/Benzoic acid, 4-amino-3-methoxy-5-methyl-, methyl ester (9CI)
- 569345-95-5/Urea, N-(3,4-dihydroxyphenyl)-N-(hydroxymethyl)-N-methyl- (9CI)
- 569350-21-6/Benzeneacetonitrile, alpha,2-dihydroxy-, (alphaS)- (9CI)
- 569351-24-2/N-(2-(1-METHYL-1H-PYRROL-2-YL)ETHYL)FORMAMIDE
- 569351-25-3/1-METHYL-6,7-DIHYDRO-1H-PYRROLO[3,2-C]PYRIDINE
- 569364-53-0/1,3-Cyclohexadiene-1-carboxylicacid,2-ethoxy-6-methyl-,ethylester(9CI)
- 569371-09-1/1(2H)-Pyrimidinepropanoic acid, alpha-amino-3,4-dihydro-3-methyl-2,4-dioxo-, (alphaS)- (9CI)
- 569371-10-4/(AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID
- 569642-54-2/Bicyclo[3.3.1]nonane-2,6-diol, 2,4,6,8-tetramethyl-, (1R,2R,4S,5R,6R,8R)-rel- (9CI)
- 569643-00-1/1H-Imidazole-4-methanol,2-amino-4,5-dihydro-alpha-methyl-,(alphaR,4S)-rel-(9CI)
- 569643-02-3/1H-1,3-Diazepin-5-ol,2-amino-4,5,6,7-tetrahydro-(9CI)
- 569646-79-3/2-Butanone,4-(3-ethoxy-4-hydroxyphenyl)-(7CI)
- 569650-64-2/(+)-1,2-BIS((2R,5R)-2,5-DI-I-PROPYLPHOSPHOLANO)BENZENE)1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE
- 569652-74-0/1H-2-Benzopyran-4,5-diol, 3,4-dihydro-8-methoxy-1,3-dimethyl-, (1R,3R,4S)-rel- (9CI)
- 569652-83-1/1H-2-Benzopyran-4,5-diol, 3,4-dihydro-8-methoxy-1,3-dimethyl-, (1R,3S,4R)-rel- (9CI)
- 569652-85-3/1H-2-Benzopyran-4,5-diol, 3,4-dihydro-8-methoxy-1,3-dimethyl-, (1R,3S,4S)-rel- (9CI)
- 569653-44-7/Piperazine, 1-(4-ethyl-1-methyl-4-piperidinyl)- (9CI)
- 569656-49-1/Spiro[2.5]octane-1-methanol, 4-methoxy-, (1R,3S)-rel- (9CI)